Category: Pharmaceuticals
Global Pharmaceuticals
-
Global Schizophrenia Drugs Market Report by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) Treatment (Injectable, Oral) Therapeutic Class (Second Generation, Third Generation, Others) Countries and Company Analysis, 2024-2032
... drugs market will increase from US$ 7,433.1 million in 2030 to over US$ 10,132.4 million by 2032 with a CAGR of 3.50% from 2024 to 2032. This growth is as a result of the growing ... Read More
-
Global Iron-Deficiency Anemia Therapy Market
... period of 2024 to 2031. Market Segmentation: Global Iron-Deficiency Anemia Therapy Market, By Therapy (Parenteral Iron Therapy and Oral Iron Therapy), Therapy Area (Obstetrics and Gynecology, Renal Diseases, Congestive Heart Failure (CHF), Oncology, Inflammatory Bowel ... Read More
-
Advanced Orthopedic Technologies Market By Product Type (Implants, Regenerative Products) , By Application (Spine Surgery, Cranial and Maxillofacial Surgery, Joint Replacement Surgery, Others) By End User (Hospitals, Ambulatory Surgical Centers, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
... and Industry Forecast, 2024-2033 The advanced orthopedic technologies market was valued at $58.1 billion in 2023, and is projected to reach $92.1 billion by 2033, growing at a CAGR of 4.7% from 2024 to 2033. ... Read More
-
Orthopedic Implants Market By Product Type (Reconstructive Joint Replacements, Spinal Implants, Dental Implants, Trauma, Orthobiologics, Others) , By Biomaterial (Metallic Biomaterials, Ceramic Biomaterials, Polymeric Biomaterials, Others) By Type (Knee, Hip, Wrist and Shoulder, Dental, Spine, Ankle, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
... Ankle, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033 The global orthopedic implants market was valued at $49.4 Billion in 2023, and is projected to reach $76.4 Billion by 2033, growing at a CAGR ... Read More
-
Global Plant-Based Multivitamins Gummies Market Growth 2024-2030
... CAGR of %from 2024 to 2030. LP Information, Inc. (LPI) ' newest research report, the “Plant-Based Multivitamins Gummies Industry Forecast” looks at past sales and reviews total world Plant-Based Multivitamins Gummies sales in 2023, providing ... Read More
-
Global Soft Gelatin Capsules (Softgels) Market Research Report 2024
... a CAGR of 3.2% during the forecast period 2024-2030. The major global manufacturers of Soft Gelatin Capsules (Softgels) include Catalent, Aenova, Nature’s Bounty, Procaps, Patheon (Thermo Fisher Scientific), Aland, EuroCaps, Captek, and Strides Pharma Science, ... Read More
-
Allergy Treatment
... at a CAGR of 3.8% over the analysis period 2023-2030. Asthma Treatment, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$5.9 Billion by the end of ... Read More
-
Clinical Nutrition Products
... by 2030, growing at a CAGR of 4.1% over the analysis period 2023-2030. Oral Nutrition, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$28.7 Billion by ... Read More
-
DPP-IV Inhibitors
... at a CAGR of 1.7% over the analysis period 2023-2030. The U.S. Market is Estimated at US$3.4 Billion While China is Forecast to Grow at 1.7% CAGR The DPP-IV Inhibitors market in the U.S. is ... Read More
-
High Content Screening (HCS)
... reach US$2.2 Billion by 2030, growing at a CAGR of 9.1% over the analysis period 2023-2030. HCS Instruments, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach ... Read More
-
Human Reproductive Technologies
... by 2030, growing at a CAGR of 2.3% over the analysis period 2023-2030. Contraceptive Drugs & Devices, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$22.0 ... Read More
-
Biosimulation Technology
... at a CAGR of 15.7% over the analysis period 2023-2030. Biosimulation Software, one of the segments analyzed in the report, is expected to record a 14.9% CAGR and reach US$5.7 Billion by the end of ... Read More
-
HIV/AIDS Testing
... at a CAGR of 6.1% over the analysis period 2023-2030. HIV/AIDS Testing Instruments, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$3.6 Billion by the end ... Read More
-
Insulin Delivery Systems
... by 2030, growing at a CAGR of 3.3% over the analysis period 2023-2030. Syringes, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$7.0 Billion by the ... Read More
-
Coenzyme Q10
... at a CAGR of 4.6% over the analysis period 2023-2030. Dietary Supplements Application, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$609.1 Million by the end ... Read More
-
Parenteral Nutrition
... at a CAGR of 6.7% over the analysis period 2023-2030. Single Dose Amino Acid Solution, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$4.1 Billion by ... Read More
-
Nanotechnology in Drug Delivery
... reach US$122.7 Billion by 2030, growing at a CAGR of 8.0% over the analysis period 2023-2030. Nanoparticles, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$35.6 ... Read More
-
Acute Heart Failure (AHF) Therapeutics
... is expected to reach US$2.9 Billion by 2030, growing at a CAGR of 21.3% over the analysis period 2023-2030. Cardiac Glycosides, one of the segments analyzed in the report, is expected to record a 21.8% ... Read More
-
Algae Omega 3 Ingredients
... reach US$2.4 Billion by 2030, growing at a CAGR of 10.2% over the analysis period 2023-2030. EPA / DHA, one of the segments analyzed in the report, is expected to record a 11.1% CAGR and ... Read More
-
Global Varicella Virus Vaccine Market Research Report 2024(Status and Outlook)
... Size was estimated at USD 3304.96 million in 2023 and is projected to reach USD 4822.41 million by 2029, exhibiting a CAGR of 6.50% during the forecast period. This report provides a deep insight into ... Read More
-
Global Iodine-131 Market Research Report 2024
... during the forecast period 2024-2030. North American market for Iodine-131 is estimated to increase from $ 653.88 thousand USD in 2023 to reach $ 891.04 thousand USD by 2030, at a CAGR of 4.78% during ... Read More
-
Intranasal Drug Delivery
... by 2030, growing at a CAGR of 6.6% over the analysis period 2023-2030. Liquid Delivery Devices, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$38.0 Billion ... Read More
-
Astaxanthin
... of 6.7% over the analysis period 2023-2030. Feed Application, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$380.2 Million by the end of the analysis period. ... Read More
-
Gastrointestinal OTC Drugs Market by Drug Class (Laxatives, Gastrointestinal Cancer Treatments, Gastric Acid Reducers, Anti-Diarrheal, Proton Pump Inhibitors, H2 Inhibitors, Gastric Acid Neutralizers, Bowel Anti-Inflammatory, Anti-Emetics), Indication (Gastroesophageal Reflux Disease (GERD) or Heartburn, Constipation, Diarrhea, Motion Sickness, and Others), End User (Hospitals, Clinics, and Others), and Region 2024-2032
... Motion Sickness, and Others), End User (Hospitals, Clinics, and Others), and Region 2024-2032 The global gastrointestinal OTC drugs market size reached US$ 42.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach ... Read More
-
T-cell Lymphoma Market Size, Share & Trends Analysis Report By Type (Peripheral, Lymphoblastic), By Therapy (Radiotherapy, Immunotherapy, Stem Cell Transplantation), By Region, And Segment Forecasts, 2024 - 2030
... global T-cell lymphoma market size is anticipated to reach USD 3.70 billion by 2030, expanding at a CAGR of 8.83% from 2024 to 2030, according to a new report by Grand View Research, Inc. The ... Read More
Research Assistance
